Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa J LaBonte

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Pharmacogenomics|November 7, 2013
Role of cyclin polymorphisms in predicting outcome of 5-fluorouracil-based chemotherapy in colorectal cancer: one piece in a complex puzzleMelissa J LaBonte, Heinz-Josef Lenz
Gastroenterology Clinics of North America|February 21, 2012
Pancreatic cancer: medical management (novel chemotherapeutics)David Páez, Melissa J Labonte, Heinz-Josef Lenz
Clinical Colorectal Cancer|August 23, 2011
A review of excision repair cross-complementation group 1 in colorectal cancerPierre Bohanes, Melissa J Labonte, Heinz-Josef Lenz
Cancer Journal (Sudbury, Mass.)|June 8, 2010
Molecular markers in the treatment of metastatic colorectal cancerPeter M Wilson, Melissa J Labonte, Heinz-Josef Lenz
Cancer Chemotherapy and Pharmacology|October 12, 2012
Assessing the in vivo efficacy of biologic antiangiogenic therapiesPeter M Wilson, Melissa J LaBonte, Heinz-Josef Lenz
Seminars in Oncology|August 4, 2011
Predictive molecular classifiers in colorectal cancerPierre Bohanes, Melissa J LaBonte, Thomas Winder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2013
Molecular pathways: Estrogen pathway in colorectal cancerAfsaneh Barzi, Annika Medea Lenz, Melissa J Labonte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
"HER majesty's a pretty nice girl but she changes from day to day"Pierre Bohanes, Fotios Loupakis, Melissa J Labonte, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 23, 2018
Protocols for Studies on Genetically Engineered Mouse Models in Prostate CancerChris W D Armstrong, Oksana Lyubomska, Melissa J LaBonte, et al.
International Journal of Cancer|April 23, 2009
Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cellsWilliam Fazzone, Peter M Wilson, Melissa J Labonte, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Pharmacogenomics|November 7, 2013
Role of cyclin polymorphisms in predicting outcome of 5-fluorouracil-based chemotherapy in colorectal cancer: one piece in a complex puzzleMelissa J LaBonte, Heinz-Josef Lenz
Gastroenterology Clinics of North America|February 21, 2012
Pancreatic cancer: medical management (novel chemotherapeutics)David Páez, Melissa J Labonte, Heinz-Josef Lenz
Clinical Colorectal Cancer|August 23, 2011
A review of excision repair cross-complementation group 1 in colorectal cancerPierre Bohanes, Melissa J Labonte, Heinz-Josef Lenz
Cancer Journal (Sudbury, Mass.)|June 8, 2010
Molecular markers in the treatment of metastatic colorectal cancerPeter M Wilson, Melissa J Labonte, Heinz-Josef Lenz
Cancer Chemotherapy and Pharmacology|October 12, 2012
Assessing the in vivo efficacy of biologic antiangiogenic therapiesPeter M Wilson, Melissa J LaBonte, Heinz-Josef Lenz
Seminars in Oncology|August 4, 2011
Predictive molecular classifiers in colorectal cancerPierre Bohanes, Melissa J LaBonte, Thomas Winder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2013
Molecular pathways: Estrogen pathway in colorectal cancerAfsaneh Barzi, Annika Medea Lenz, Melissa J Labonte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
"HER majesty's a pretty nice girl but she changes from day to day"Pierre Bohanes, Fotios Loupakis, Melissa J Labonte, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 23, 2018
Protocols for Studies on Genetically Engineered Mouse Models in Prostate CancerChris W D Armstrong, Oksana Lyubomska, Melissa J LaBonte, et al.
International Journal of Cancer|April 23, 2009
Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cellsWilliam Fazzone, Peter M Wilson, Melissa J Labonte, et al.
Pageof 5